Myopia control is not my preferred terminology because it is not a comprehensive term.
Feb. 12, 2020 The cover topic of the February 2020 edition of Vision Monday reports on “Myopia Management: Developing Myopia as a...
It is your Reptilian Brain that holds you back.
Few studies have analyzed the effectiveness of outdoor light exposure intervention programs in slowing myopia progression.
These recommendations did not receive the media attention they deserved.
MiSight® 1 day’s FDA approval is an important step forward in stopping the myopia epidemic facing American children.
Results of a recent study on combining orthokeratology and topical atropine 0.01%.
Presently, only atropine, pirenzepine, and 7-methylxanthine are shown to reduce myopia progression in human trials.
When I speak with eye care professionals I am surprised by how much snake oil exists.
The researchers concluded that topical low-dose atropine appears to be safe and effective in a cohort of European schoolchildren.
RMM circulates to more than 55,000 eye care professionals in the United States, Canada, and globally.
Jobson Medical Information will be the official North American media sponsor.
Jobson Optical Research, sponsored by Essilor, polled more than 300 optometrists in the U.S.
Results of a recent survey spanning eight years.
Myopia develops at different rates in different children.
Myopia was once considered a simple refractive error with few, if any, long-term eye health consequences.
By Dwight Akerman, OD, MBA, FAAO Chief Medical Editor, Review of Myopia Management During May 2019, Jobson Optical Research, sponsored by Essilor,...
The effect of overnight orthokeratology
While we have much to learn about myopia management in children and teenagers, we already know so much.
Congratulations to all who created the International Myopia Institute (IMI) Myopia White Papers.
Many do not understand the significance of myopia to potential ocular health issues.